CDEK
← All organizations

Cutanea Life Sciences, Inc.

For profitWebsite ↗

Also known as: CUTANEA | Cutanea Life Sciences, Inc.

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 3

First clinical trial

Mar 1, 2013

Last known activity

Oct 31, 2018

Acquired by Biofrontera Bioscience GmbH on Mar 25, 2019

Timeline

2000s

  1. Nov 27, 2000

    erythromycin— Marketing Organization

  2. Jun 1, 2005

    Cutanea Life Sciences, Inc.— Founded

2010s

  1. Mar 25, 2019

    Biofrontera Bioscience GmbH— Acquired By

Drugs by trial phase (6 distinct, 20 trials)

Phase 3 (2 own, 0 via acquisition)

Phase 2 (3 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (1)

Recent trials (20)

Details

Founded
Wayne, PA, US Jun 1, 2005
Last known activity
Oct 31, 2018